THELMA Therapeutics Co., Ltd. announced a private placement of common shares for gross proceeds of KRW 4,999,999,900 on December 20, 2021. The transaction will include participation from new investor H-TREPORT for 34.68% stake in the company. The company will receive funding through third party allotment of capital.